Clinical Trial Update: Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study [NA]

View source ↗

Summary

Clinical trial update for Xeltis's XPAD Bypass Conduit Early Feasibility Study in peripheral artery occlusive disease; study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Occlusive Disease

Drugs mentioned

• XPAD Bypass Conduit

Snippet

Sponsor: Xeltis | Conditions: Peripheral Artery Occlusive Disease | NA | Status: RECRUITING